Can advanced non-small-cell lung cancer be treated with weekly instead of 3-weekly docetaxel?

被引：3
|
作者：
Scagliotti, G. V. [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, S Luigi Hosp Reg Gozole 10, I-10043 Turin, Italy
[2] S Luigi Hosp, Thorac Oncol Unit, Turin, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 06期
关键词：
docetaxel; non-small-cell lung cancer; schedule; survival; toxicity;
D O I：
10.1038/ncponc0510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：294 / 295
页数：2
相关论文
共 50 条
  • [21] Weekly administration of gemcitabine plus docetaxel in advanced non-small cell lung cancer (NSCLC).
    Sun, Y
    Li, J
    Wu, Y
    Li, L
    Gu, L
    Zhang, L
    Wang, J
    Zhang, X
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [22] Comparison of 2-Weekly and 3-Weekly Dosing of Docetaxel in Metastatic Prostate Cancer
    Martinez-Recio, Sergio
    Perez-Wert, Juan Pablo
    Martinez-Fdez, Sara
    Jimenez-Bou, Diego
    Ruiz-Gutierrez, Iciar
    Pena, Jesus
    Pertejo, Ana
    Espinosa, Enrique
    Pinto, Alvaro
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : 363 - 370
  • [23] THE COMPARATIVE EVALUATION OF RADIOTHERAPY WITH CONCURRENT WEEKLY CISPLATIN VERSUS CONCURRENT 3-WEEKLY CISPLATIN AND ETOPOSIDE IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
    Bagri, P. K.
    Hirapara, P.
    Kapoor, A.
    Singhal, M.
    Singh, D.
    Jakhar, S. L.
    Beniwal, S. K.
    Sharma, N.
    Kumar, H.
    Sharma, A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S35 - S36
  • [24] Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: A phase II trial of sequential chemotherapy
    Dols M.C.
    Chamorro E.V.
    Díaz I.A.
    Calle S.G.
    García J.A.
    Calderón V.G.
    Ocón F.C.
    Pino Á.M.
    Bretón García J.J.
    Orgaz M.B.
    Clinical and Translational Oncology, 2006, 8 (10) : 742 - 749
  • [25] A PHASE II TRIAL OF WEEKLY DOCETAXEL COMBINED WITH CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG CANCER
    Nong, X.
    Zhang, X.
    Xiong, J.
    Fang, W.
    Zhang, L.
    Zhong, L.
    Chen, J.
    Yu, F.
    Qian, J.
    Deng, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
  • [26] Development of docetaxel in advanced non-small-cell lung cancer
    Belani, CP
    Eckardt, J
    LUNG CANCER, 2004, 46 : S3 - S11
  • [27] Docetaxel for previously treated non-small-cell lung cancer
    Fossella, FV
    ONCOLOGY-NEW YORK, 2002, 16 (06): : 45 - 51
  • [28] Docetaxel in the treatment of advanced non-small-cell lung cancer
    Saloustros, Emmanouel
    Georgoulias, Vassilis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1207 - 1222
  • [29] Gefitinib or docetaxel in advanced non-small-cell lung cancer
    Cullen, Michael
    Thatcher, Nicholas
    LANCET, 2008, 372 (9652): : 1785 - 1786
  • [30] Weekly paclitaxel in advanced non-small cell lung cancer
    Chang, AYC
    Rubins, J
    Asbury, R
    Boros, L
    Hui, LF
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 10 - 13
12345